Heyu Biological Technology Corporation reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 0.014387 million compared to USD 0.053613 million a year ago. Net loss was USD 0.095251 million compared to USD 0.010738 million a year ago.
For the six months, sales was USD 0.029522 million compared to USD 0.053613 million a year ago. Net loss was USD 0.145306 million compared to USD 0.100554 million a year ago.